Painful Sex During Menopause: How to Treat Dyspareunia with Scientific Evidence
A clinically-informed, empathetic guide backed by the most current guidelines on treating dyspareunia during menopause.
What dyspareunia is, and how many women experience it
Dyspareunia is persistent or recurring genital pain that occurs before, during, or after sex. It isn't a minor symptom, and it isn't something that should be normalized: it's one of the most common manifestations of Genitourinary Syndrome of Menopause (GSM), a recognized clinical entity covering the vaginal, sexual, and urinary changes caused by falling estrogen.
A cross-sectional study of 411 women in the menopause transition found that pain during sex was, after low libido, the most commonly reported sexual dysfunction in the group. And a troubling pattern repeats across studies: most women with dyspareunia never bring it up with a healthcare provider.
Why staying silent makes it worse
According to current clinical literature, Genitourinary Syndrome of Menopause is a chronic, progressive condition: unlike hot flashes, it doesn't improve on its own over time. The longer treatment is delayed, the more the tissue atrophies, and the harder the pain becomes to reverse.
Why it happens: the hormonal cause behind the pain
As estrogen levels fall during menopause, the vaginal epithelium thins and loses elasticity, while activity in the vaginal glands drops noticeably. The direct result is less natural lubrication and, for many women, dryness and pain during penetration.
The further postmenopause progresses, the more this atrophy tends to intensify: dryness and pain symptoms tend to become more noticeable over time, not less. It's a progressive process, not a one-off episode that will just pass.
"With dyspareunia, a woman's body image and genital self-image both suffer (...) she feels less sexually desirable and less feminine." — Review on the physical and psychosocial-sexual factors of dyspareunia, Psicología Científica
This is a key point that often gets overlooked: dyspareunia isn't just a physical problem. Repeated pain generates anticipatory anxiety, avoidance of intimacy, and, over time, can lead to vaginismus (involuntary spasms of the vaginal muscles that make penetration even harder). That's why acting early — before the pain-avoidance cycle sets in — matters so much.
The stepped treatment approach recommended by 2025-2026 clinical guidelines
The good news is that menopausal dyspareunia has a well-established treatment protocol, backed by the most recent clinical guidelines (NAMS, EMAS, NICE, and AUA/SUFU/AUGS 2025). The approach follows a stepped path, from lower to higher intervention:
| Line | Treatment | When it's indicated |
|---|---|---|
| 1st line | Non-hormonal vaginal lubricants and moisturizers, used regularly | Mild-to-moderate symptoms, always the first option |
| 2nd line | Low-dose vaginal estrogen (creams, inserts, tablets) | Persistent symptoms; minimal systemic absorption |
| Alternatives | Ospemifene (oral SERM) or vaginal prasterone/DHEA | Moderate-to-severe dyspareunia, or when estrogen is best avoided |
| Experimental | CO₂ / Er:YAG laser | Evidence still limited and debated per AUA/SUFU/AUGS 2025; not first-line |
It's worth noting that low-dose vaginal estrogen has minimal systemic absorption and generally doesn't require added progestogen for endometrial protection — a common concern among those hesitant to start local hormonal treatment.
GSM is systematically under-treated
A 2026 review concludes that Genitourinary Syndrome of Menopause remains underdiagnosed and undertreated, and calls for healthcare providers to take a more active role in screening, information, and individualized treatment. If no one has ever asked you about this in an appointment, that doesn't mean there's no solution — it means you'll likely need to bring it up yourself.
The role of stimulation and material in recovery
Beyond first-line medical treatment, regular genital stimulation — whether partnered or solo — plays an active role in vaginal tissue health. Stimulation supports local blood flow, which helps maintain elasticity and natural lubrication, complementing — never replacing — the treatment prescribed by your gynecologist.
Why does the material of the product you use matter too? On tissue already sensitized by atrophy, hard or cold-feeling materials can trigger involuntary muscle tension — the exact opposite of what you want when treating dyspareunia. Dual-density medical silicone, with a soft outer layer that gives on contact, reduces pressure points on already fragile tissue.
- Always use a water-based or compatible medical-grade silicone lubricant — never dry friction. Check our lubricant compatibility guide if you're unsure.
- Start with external stimulation before any penetration, giving the tissue time to respond.
- Prioritize thermoreactive materials: sudden cold contracts the pelvic muscles and can make pain worse.
- Progress gradually, without forcing it; the goal is rebuilding a positive association with intimacy, not proving you can tolerate pain.
Discover the SILEXD collection
Dual-density medical silicone, thermoreactive, with no pressure on fragile tissue.
When to see a specialist
See your gynecologist or a pelvic floor physical therapist if:
- The pain is intense, constant, or appeared suddenly and recently.
- First-line lubricants and moisturizers aren't improving symptoms after several weeks of regular use.
- You notice bleeding after sex (any postmenopausal bleeding should always be evaluated).
- The pain is leading you to avoid intimacy entirely, or you suspect vaginismus may be developing.
- You have a history of breast cancer or another condition requiring individualized hormonal treatment.
The good news: even for women with a history of cancer, specific, up-to-date protocols now exist to treat GSM safely, coordinated between gynecology and oncology.
Frequently asked questions
Does dyspareunia go away on its own over time?
No. Unlike hot flashes, which tend to fade with the years, GSM and the dyspareunia it causes is progressive. Without intervention, symptoms tend to worsen, not improve.
Is vaginal estrogen safe if I have a history of breast cancer?
Specific, updated (2026) guidelines exist for managing GSM in women with a breast cancer history. The decision should always be made together with your oncology and gynecology team, individualized to your case.
Is dyspareunia the same as vaginismus?
No, though they're related. Dyspareunia is genital pain during sex; vaginismus is the involuntary contraction of the vaginal muscles that can prevent penetration entirely. Untreated dyspareunia can develop into vaginismus over time.
Is vaginal laser a good option?
Per the AUA/SUFU/AUGS 2025 guideline, evidence on energy-based therapies (CO₂, Er:YAG laser) remains promising but debated, and they aren't considered first-line treatment. If you're considering it, do so at a center with specific expertise, and after trying validated options first.
How long does it take to see improvement with treatment?
With regular use of moisturizers and lubricants, some women notice relief within a few weeks. With low-dose vaginal estrogen, the usual protocol is daily application for 2–4 weeks, then tapering to 1–2 times a week depending on response.
This isn't something you have to just live with
Pain during sex in menopause has an identified cause, a treatment protocol validated by the latest evidence, and options that adapt to your situation — whatever your health history looks like.
Asking for help isn't overreacting. It's the difference between living intimacy in fear or getting back to living it with confidence.
Keep reading: therapeutic vibration and pelvic floor health and our lubricant compatibility guide.
Shop the Vibrations Collection